DE69004425D1 - Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen. - Google Patents

Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.

Info

Publication number
DE69004425D1
DE69004425D1 DE90907580T DE69004425T DE69004425D1 DE 69004425 D1 DE69004425 D1 DE 69004425D1 DE 90907580 T DE90907580 T DE 90907580T DE 69004425 T DE69004425 T DE 69004425T DE 69004425 D1 DE69004425 D1 DE 69004425D1
Authority
DE
Germany
Prior art keywords
producing
viral infections
aliphatic alcohols
medicinal product
treating viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE90907580T
Other languages
English (en)
Other versions
DE69004425T2 (de
Inventor
David Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIDAK PHARMACEUTICALS LA JOLLA
Original Assignee
LIDAK PHARMACEUTICALS LA JOLLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/345,084 external-priority patent/US4874794A/en
Application filed by LIDAK PHARMACEUTICALS LA JOLLA filed Critical LIDAK PHARMACEUTICALS LA JOLLA
Application granted granted Critical
Publication of DE69004425D1 publication Critical patent/DE69004425D1/de
Publication of DE69004425T2 publication Critical patent/DE69004425T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE90907580T 1989-04-28 1990-04-16 Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen. Expired - Lifetime DE69004425T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment
US07/431,304 US5071879A (en) 1989-04-28 1989-11-02 Systemic antiviral treatment

Publications (2)

Publication Number Publication Date
DE69004425D1 true DE69004425D1 (de) 1993-12-09
DE69004425T2 DE69004425T2 (de) 1994-02-24

Family

ID=26994246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90907580T Expired - Lifetime DE69004425T2 (de) 1989-04-28 1990-04-16 Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.

Country Status (8)

Country Link
US (1) US5071879A (de)
EP (1) EP0469064B1 (de)
JP (1) JP3064010B2 (de)
AT (1) ATE96662T1 (de)
DE (1) DE69004425T2 (de)
DK (1) DK0469064T3 (de)
ES (1) ES2062529T3 (de)
WO (1) WO1990013287A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ES2242582T3 (es) 1999-09-03 2005-11-16 Cabby Business Inc. Procedimiento de alta eficiencia para la preparacion de esteroles de alta pureza.
US20030018074A1 (en) * 2001-07-06 2003-01-23 Robert Kleiman Antiviral composition and treatment method
YU31104A (sh) * 2001-10-16 2006-08-17 Avanir Pharmaceuticals Inhibicija virusa n-dokozanolom
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
DE3318989C2 (de) * 1982-05-28 1996-11-21 Eisai Co Ltd ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
IT1203934B (it) * 1987-04-17 1989-02-23 Consiglio Nazionale Ricerche Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury

Also Published As

Publication number Publication date
ATE96662T1 (de) 1993-11-15
JPH05501542A (ja) 1993-03-25
DK0469064T3 (da) 1994-03-21
EP0469064B1 (de) 1993-11-03
WO1990013287A1 (en) 1990-11-15
JP3064010B2 (ja) 2000-07-12
DE69004425T2 (de) 1994-02-24
US5071879A (en) 1991-12-10
EP0469064A1 (de) 1992-02-05
ES2062529T3 (es) 1994-12-16

Similar Documents

Publication Publication Date Title
ATE121907T1 (de) Methoden zur verhinderung von schimmel.
DE69003652D1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
DE59000270D1 (de) Verwendung von mindestens ein cytokin zur herstellung eines arzneimittels zur systemischen behandlung von praeneoplastischen laesionen.
MY110734A (en) Improvements in or relating to dioic acids.
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3851203D1 (de) Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
ATE135208T1 (de) Verwendung von nervonsäure und langkettiger fettsäuren zur behandlung demyelinisierender erkrankungen
ATE120954T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
ATE184193T1 (de) Verwendung von n-acylaminoalkoholen zur herstellung eines arzneimittels zur behandlung von mastzellerkrankungen
DE69004425T2 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
PT79648B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darm-bereich
ES8102141A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7
ES483661A1 (es) Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
DE3850778T2 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE3780814T2 (de) Verwendung von nukleosiden zur herstellung eines medikamentes zur behandlung von krankheiten, die durch einen retrovirus oder den hepatitis-b-virus verursacht werden.
DE69026511D1 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
GR3001793T3 (en) Polyprenyl alcohol-containing injections and use thereof
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
MX19953A (es) Procedimiento para la preparacion de nuevas benzo tiopiranilaminas, producto obtenido y composicion farmaceutica que lo incluye.
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
BE875696A (fr) Attractant composite d'insectes, notamment des mamestres males du chou et procede de preparation des constituants actifs de cet attractant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition